Evidence map›Paper›PMID 28432330›Full record

ArticleScientific reports2017

Enhanced Response of Metformin towards the Cancer Cells due to Synergism with Multi-walled Carbon Nanotubes in Photothermal Therapy.

Sweejiang Yoo, Jin Hou, Wenhui Yi, Yingchun Li, Weiping Chen, Lingjie Meng, Jinhai Si, Xun Hou

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sweejiang YooKey Laboratory for Physical Electronics and Devices of the Ministry of Education & Key Laboratory for Information Photonic Technology of ShaanXi Province, School of Information and Electronics Engineering, Xi'an Jiaotong University, Xi'an, 710049, China.
Jin HouDepartment of Pharmacology, School of Basic Medical Sciences, Xi'an Medical University, Xi'an, 710021, China.
Wenhui YiKey Laboratory for Physical Electronics and Devices of the Ministry of Education & Key Laboratory for Information Photonic Technology of ShaanXi Province, School of Information and Electronics Engineering, Xi'an Jiaotong University, Xi'an, 710049, China. yiwenhui@mail.xjtu.edu.cn.
Yingchun LiKey Laboratory for Physical Electronics and Devices of the Ministry of Education & Key Laboratory for Information Photonic Technology of ShaanXi Province, School of Information and Electronics Engineering, Xi'an Jiaotong University, Xi'an, 710049, China.
Weiping ChenDepartment of Pharmacology, School of Basic Medical Sciences, Xi'an Medical University, Xi'an, 710021, China.
Lingjie MengDepartment of Applied Chemistry, School of Science, Xi'an Jiaotong University, Xian, 710049, China. menglingjie@mail.xjtu.edu.cn.
Jinhai SiKey Laboratory for Physical Electronics and Devices of the Ministry of Education & Key Laboratory for Information Photonic Technology of ShaanXi Province, School of Information and Electronics Engineering, Xi'an Jiaotong University, Xi'an, 710049, China.
Xun HouKey Laboratory for Physical Electronics and Devices of the Ministry of Education & Key Laboratory for Information Photonic Technology of ShaanXi Province, School of Information and Electronics Engineering, Xi'an Jiaotong University, Xi'an, 710049, China.
Xi'an Jiaotong University · CNXi'an Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Converging evidence from laboratory models pointed that the widely used antidiabetic drug metformin has direct effects on cancer cells. Thus far, relatively little attention has been addressed to the drug exposures used experimentally relative to those achievable clinically. Here, we demonstrated that metformin loaded on carbon nanotubes under near-infrared (NIR) irradiation led to the remarkably enhancement in response towards cancer cells. The dose of metformin has reduced to only 1/280 of typical doses in monotherapy (35: 10 000-30 000 µM) where the realization of metformin in conventional antidiabetic doses for cancer therapies becomes possible. The heat generated from carbon nanotubes upon NIR irradiation has mediated a strong and highly localized hyperthermia-like condition that facilitated the enhancement. Our work highlight the promise of using highly localized heating from carbon nanotubes to intensify the efficacy of metformin for potential cancer therapies.

Indexed as

Drug CarriersDrug SynergismNanotubes, CarbonAntineoplastic AgentsCell SurvivalHep G2 CellsHumansHyperthermia, InducedHypoglycemic AgentsInfrared RaysMetforminPhototherapyAntineoplastic AgentsDrug CarriersHypoglycemic AgentsMetforminNanotubes, Carbon

Identifiers

PMID28432330
PMCPMC5430827
OpenAlexW2605478097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.